Discovery
Seattle Children's Hospital picks up USD 2.1m NIH grant for AI nanobody engineering platform
An AI-driven approach to nanobody engineering is drawing federal support, with Seattle Children's Hospital receiving a USD 2.1 million NIH R01 grant to...
HCW Biologics' fusion immunotherapeutic prevents bronchopulmonary dysplasia in preclinical models
HCW Biologics reports HCW11-040 prevents bronchopulmonary dysplasia in IND-enabling animal studies
Silexion's RNAi therapy shows increased MHC-I surface expression in preclinical models of KRAS-mutated pancreatic cancer
Silexion Therapeutics (Nasdaq: SLXN), a Cayman Islands-based clinical-stage biotechnology company, has reported preclinical data showing that its lead siRNA...
Army Medical University demonstrates hepatic APOE3 Christchurch gene therapy reduces Alzheimer's pathology in Neuron
Researchers at Army Medical University (Third Military Medical University) in Chongqing, China report that liver-directed delivery of the APOE3 Christchurch...
University of Washington receives USD 1.2m NIH R35 award for cardiovascular-diabetes research
The [University of Washington](https://app.allsci.com/organization/ASC-OH-0000000000030-1.0-1764853177) has received a USD 1.2 million NHLBI R35 award to investigate the lipoprotein mechanisms driving cardiovascular disease risk in youth with diabetes, reflecting sustained National Institutes of Health interest in closing the translational gap between metabolic biology and early vascular preventio
University of Virginia receives USD 1.44m NIH grant for type 1 diabetes alternative splicing research
Alternative splicing emerges as a mechanistic focus in type 1 diabetes risk research, with the University of Virginia receiving USD 1.44 million from NIDDK...
University of Washington receives USD 2.1m NIH award for spatial transcriptomics technology development
A USD 2.1 million NIH R01 award positions the University of Washington at the center of an emerging effort to overcome a fundamental throughput bottleneck...
National Eye Institute awards USD 1.03m to Houston Methodist for mitochondrial dysfunction AMD therapy
A preclinical program targeting mitochondrial dysfunction in dry age-related macular degeneration has received USD 1.03 million in NIH R56 funding from the...
Trinity College Dublin researchers identify NK cell dysfunction in neovascular AMD
Researchers at Trinity College Dublin in Ireland, working with collaborators at the Royal Victoria Eye and Ear Hospital and using population data from the...
Mount Sinai, Memorial Sloan Kettering explore colorectal cancer immune resistance with quadruple checkpoint combo
Researchers at the Icahn School of Medicine at Mount Sinai in New York, with contributions from Memorial Sloan Kettering Cancer Center, report that a...
Pershing Square Sohn Cancer Alliance awards USD 9m to 13 early-career cancer researchers
The Pershing Square Sohn Cancer Research Alliance has awarded USD 9 million across 13 early-career investigators through the 2026 Pershing Square Sohn...
Ovarian Cancer Canada hands USD 725k to natural killer cell immunotherapy program at Dalhousie University
Ovarian Cancer Canada has announced USD 725,000 in ovarian cancer treatment funding for a natural killer (NK) cell immunotherapy program led by Dr. Jeanette...
National Pediatric Cancer Foundation awards USD 1m grant to Children's Hospital Los Angeles for rhabdomyosarcoma research
The National Pediatric Cancer Foundation has awarded a USD 1 million pediatric cancer research grant to JinSeok Park, PhD, at Children's Hospital Los...
UNC Chapel Hill receives USD 1.1m NIH grant for HIV and contraception prevention implant
The University of North Carolina at Chapel Hill has received USD 1.1 million in first-year funding from the National Institute of Allergy and Infectious...
University of Southern California receives USD 1.26m NIEHS grant for PFAS metabolic disease research
The University of Southern California has received an NIEHS PFAS grant totaling USD 1,256,897 in first-year funding through the National Institute of...
The AllSci Brief
Free, systematic R&D and deal news. Daily.